Saffron Appetite Randomized Trial Evidence Table

Structured evidence table for Saffron Appetite Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Saffron Appetite Randomized TrialHowever, due to some potentially significant adverse events associated with its medicinal use at higher doses or prolonged administration, clinical monitoring should be considered.1Hasheminasab FS (2026)Adverse Events of Saffron (<i>Crocus sativus</i> L.): Systematic Review of Current Evidence.
Saffron Appetite Randomized TrialBackground Crocus sativus L., commonly known as saffron, is a widely used spice with a rich history of culinary and medicinal applications.1Hasheminasab FS (2026)Adverse Events of Saffron (<i>Crocus sativus</i> L.): Systematic Review of Current Evidence.
Saffron Appetite Randomized TrialThis systematic review aims to compile human data from studies on monopreparations of C.1Hasheminasab FS (2026)Adverse Events of Saffron (<i>Crocus sativus</i> L.): Systematic Review of Current Evidence.
Saffron Appetite Randomized TrialDysregulated adipogenesis in obesity involves excessive preadipocyte recruitment and differentiation, leading to increased adipocyte number (hyperplasia) and hypertrophy.3Marie Ohoud M. (2026)Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions
Saffron Appetite Randomized TrialIn obesity, lipolytic capacity is suppressed through multiple mechanisms including impaired sympathetic nervous system signaling and reduced expression of lipolytic enzymes (Thorp and Schlaich ).3Marie Ohoud M. (2026)Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions
Saffron Appetite Randomized TrialAt the molecular level, obesity‐associated chronic inflammation and elevated circulating free fatty acids impair leptin signaling through the hypothalamic leptin receptor (Jais and Brüning ).3Marie Ohoud M. (2026)Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions
Saffron Appetite Randomized Trial2025 2025 2025 2025 2023 Obesity represents one of the most pressing public health challenges of the 21st century, characterized by excessive accumulation of adipose tissue that impairs health and quality of life (Ahmed and Mohammed ; Lewandowska et al. ).3Marie Ohoud M. (2026)Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions
topicSaffron Appetite Randomized Trial
claimHowever, due to some potentially significant adverse events associated with its medicinal use at higher doses or prolonged administration, clinical monitoring should be considered.
evidence level1
citationHasheminasab FS (2026)
sourceAdverse Events of Saffron (<i>Crocus sativus</i> L.): Systematic Review of Current Evidence.
topicSaffron Appetite Randomized Trial
claimBackground Crocus sativus L., commonly known as saffron, is a widely used spice with a rich history of culinary and medicinal applications.
evidence level1
citationHasheminasab FS (2026)
sourceAdverse Events of Saffron (<i>Crocus sativus</i> L.): Systematic Review of Current Evidence.
topicSaffron Appetite Randomized Trial
claimThis systematic review aims to compile human data from studies on monopreparations of C.
evidence level1
citationHasheminasab FS (2026)
sourceAdverse Events of Saffron (<i>Crocus sativus</i> L.): Systematic Review of Current Evidence.
topicSaffron Appetite Randomized Trial
claimDysregulated adipogenesis in obesity involves excessive preadipocyte recruitment and differentiation, leading to increased adipocyte number (hyperplasia) and hypertrophy.
evidence level3
citationMarie Ohoud M. (2026)
sourceObesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions
topicSaffron Appetite Randomized Trial
claimIn obesity, lipolytic capacity is suppressed through multiple mechanisms including impaired sympathetic nervous system signaling and reduced expression of lipolytic enzymes (Thorp and Schlaich ).
evidence level3
citationMarie Ohoud M. (2026)
sourceObesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions
topicSaffron Appetite Randomized Trial
claimAt the molecular level, obesity‐associated chronic inflammation and elevated circulating free fatty acids impair leptin signaling through the hypothalamic leptin receptor (Jais and Brüning ).
evidence level3
citationMarie Ohoud M. (2026)
sourceObesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions
topicSaffron Appetite Randomized Trial
claim2025 2025 2025 2025 2023 Obesity represents one of the most pressing public health challenges of the 21st century, characterized by excessive accumulation of adipose tissue that impairs health and quality of life (Ahmed and Mohammed ; Lewandowska et al. ).
evidence level3
citationMarie Ohoud M. (2026)
sourceObesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions

Source documents

  1. Adverse Events of Saffron (<i>Crocus sativus</i> L.): Systematic Review of Current Evidence.
  2. Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions